Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy

Front Endocrinol (Lausanne). 2022 May 25;13:816400. doi: 10.3389/fendo.2022.816400. eCollection 2022.

Abstract

Diabetic nephropathy (DN) and diabetic retinopathy (DR) are microvascular complications of diabetes. Microvascular endothelial cells are thought to be the major targets of hyperglycemic injury. In diabetic microvasculature, the intracellular hyperglycemia causes damages to the vascular endothelium, via multiple pathophysiological process consist of inflammation, endothelial cell crosstalk with podocytes/pericytes and exosomes. In addition, DN and DR diseases development are involved in several critical regulators including the cell adhesion molecules (CAMs), the vascular endothelial growth factor (VEGF) family and the Notch signal. The present review attempts to gain a deeper understanding of the pathogenesis complexities underlying the endothelial dysfunction in diabetes diabetic and retinopathy, contributing to the development of new mechanistic therapeutic strategies against diabetes-induced microvascular endothelial dysfunction.

Keywords: CircRNAs; cellular crosstalk; diabetic endothelial dysfunction; diabetic nephropathy (DN); diabetic retinopathy (DR); exosomes.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus* / metabolism
  • Diabetic Nephropathies* / etiology
  • Diabetic Nephropathies* / metabolism
  • Diabetic Retinopathy* / metabolism
  • Endothelial Cells / metabolism
  • Humans
  • Hyperglycemia* / complications
  • Hyperglycemia* / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Vascular Endothelial Growth Factor A